Skip to main content

CORRECTION article

Front. Neurol., 16 March 2022
Sec. Applied Neuroimaging
Volume 13 - 2022 | https://doi.org/10.3389/fneur.2022.872851

Corrigendum: Reduced Glutamate in the Medial Prefrontal Cortex Is Associated With Emotional and Cognitive Dysregulation in People With Chronic Pain

This article is a correction to:

  1. Reduced Glutamate in the Medial Prefrontal Cortex Is Associated With Emotional and Cognitive Dysregulation in People With Chronic Pain

    1. Read original article
\nBrooke Naylor,Brooke Naylor1,2Negin Hesam-ShariatiNegin Hesam-Shariati1James H. McAuley,James H. McAuley1,3Simon BoagSimon Boag2Toby Newton-JohnToby Newton-John4Caroline D. RaeCaroline D. Rae1Sylvia M. Gustin, Sylvia M. Gustin1,5*
  • 1Neuroscience Research Australia, Sydney, NSW, Australia
  • 2School of Psychology, Macquarie University, Sydney, NSW, Australia
  • 3School of Medical Sciences, University of New South Wales, Sydney, NSW, Australia
  • 4Graduate School of Health, University of Technology Sydney, Sydney, NSW, Australia
  • 5School of Psychology, University of New South Wales, Sydney, NSW, Australia

A Corrigendum on
Reduced Glutamate in the Medial Prefrontal Cortex Is Associated With Emotional and Cognitive Dysregulation in People With Chronic Pain

by Naylor, B., Hesam-Shariati, N., McAuley, J. H., Boag, S., Newton-John, T., Rae, C. D., and Gustin, S. M. (2019). Front. Neurol. 10:1110. doi: 10.3389/fneur.2019.01110

In the original article, there was an error in the Author Contributions. It has been updated to align with the guidelines of the International Committee of Medical Journal Editors. A correction has been made to the Author Contributions.

Author Contributions

SG designed the study. SG and BN recruited subjects, collected, analyzed data, and wrote the manuscript. NH-S, TN-J, JM, SB, and CR provided substantial contributions to the interpretation of the findings and critically revised the manuscript. All authors provided approval for publication of the content and agree to be accountable for all aspects of the work.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher's Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: medial prefrontal cortex, chronic pain, spectroscopy, glutamate, N-acetylaspartate, harm avoidance, emotional dysregulation

Citation: Naylor B, Hesam-Shariati N, McAuley JH, Boag S, Newton-John T, Rae CD and Gustin SM (2022) Corrigendum: Reduced Glutamate in the Medial Prefrontal Cortex Is Associated With Emotional and Cognitive Dysregulation in People With Chronic Pain. Front. Neurol. 13:872851. doi: 10.3389/fneur.2022.872851

Received: 10 February 2022; Accepted: 25 February 2022;
Published: 16 March 2022.

Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2022 Naylor, Hesam-Shariati, McAuley, Boag, Newton-John, Rae and Gustin. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Sylvia M. Gustin, cy5ndXN0aW4mI3gwMDA0MDt1bnN3LmVkdS5hdQ==

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.